Thanos S, Heiduschka P, Stupp T
Department of Experimental Ophthalmology, University Eye Hospital and Interdisciplinary Centre of Clinical Research (IZKF), Münster, Germany.
Acta Neurochir Suppl. 2007;97(Pt 2):465-72. doi: 10.1007/978-3-211-33081-4_53.
Visual impairment and blindness is primarily caused by optic neuropathies like injuries and glaucomas, as well as retinopathies like agerelated macular degeneration (MD), systemic diseases like diabetes, hypertonia and hereditary retinitis pigmentosa (RP). These pathological conditions may affect retinal photoreceptors, or retinal pigment epithelium, or particular subsets of retinal neurons, and in particular retinal ganglion cells (RGCs). The RGCs which connect the retina with the brain are unique cells with extremely long axons bridging the distance from the retina to visual relays within the thalamus and midbrain, being therefore vulnerable to heterogeneous pathological conditions along this pathway. When becoming mature, RGCs loose the ability to divide and to regenerate their accidentally or experimentally injured axons. Consequently, any loss of RGCs is irreversible and results to loss of visual function. The advent of micro- and nanotechnology, and the construction of artificial implants prompted to create visual prostheses which aimed at compensating for the loss of visual function in particular cases. The purpose of the present contribution is to review the considerable engineering expertise that is essential to fabricate current visual prostheses in connection with their functional features and applicability to the animal and human eye. In this chapter, 1) Retinal and cortical implants are introduced, with particular emphasis given to the requirements they have to fulfil in order to replace very complex functions like vision. 2) Advanced work on material research is presented both from the technological and from the biocompatibility aspect as prerequisites of any perspectives for implantation. 3) Ultimately, experimental studies are presented showing the shaping of implants, the procedures of testing their biocompatibility and essential modifications to improve the interfaces between technical devices and the biological environment. The review ends by pointing to future perspectives in the rapidly accelerating process of visual prosthetics and in the increasing hope that restoration of the visual system becomes reality.
视力损害和失明主要由视神经病变(如损伤和青光眼)、视网膜病变(如年龄相关性黄斑变性(AMD))、全身性疾病(如糖尿病、高血压)以及遗传性视网膜色素变性(RP)引起。这些病理状况可能会影响视网膜光感受器、视网膜色素上皮或视网膜神经元的特定亚群,尤其是视网膜神经节细胞(RGC)。将视网膜与大脑相连的RGC是独特的细胞,其轴突极长,跨越从视网膜到丘脑和中脑内视觉中继的距离,因此容易受到这条通路中各种病理状况的影响。成熟后,RGC失去了分裂能力以及意外或实验性损伤轴突后再生的能力。因此,任何RGC的损失都是不可逆的,并导致视觉功能丧失。微纳技术的出现以及人工植入物的构建促使人们制造视觉假体,旨在在特定情况下补偿视觉功能的丧失。本论文的目的是回顾与当前视觉假体的功能特征及其在动物和人眼上的适用性相关的、制造这些假体所必需的大量工程专业知识。在本章中,1)介绍了视网膜和皮质植入物,特别强调了它们为取代视觉等非常复杂的功能而必须满足的要求。2)从技术和生物相容性方面介绍了材料研究的前沿工作,这是任何植入前景的先决条件。3)最终,展示了实验研究,包括植入物的成型、测试其生物相容性的程序以及为改善技术设备与生物环境之间界面而进行的必要改进。综述最后指出了视觉假体快速发展过程中的未来前景,以及恢复视觉系统成为现实的希望日益增加。